CN111686034A - Composition for external application to skin and external product for skin - Google Patents
Composition for external application to skin and external product for skin Download PDFInfo
- Publication number
- CN111686034A CN111686034A CN202010752872.9A CN202010752872A CN111686034A CN 111686034 A CN111686034 A CN 111686034A CN 202010752872 A CN202010752872 A CN 202010752872A CN 111686034 A CN111686034 A CN 111686034A
- Authority
- CN
- China
- Prior art keywords
- composition
- skin
- phase
- water
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 91
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 79
- 239000000843 powder Substances 0.000 claims abstract description 67
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 22
- 229960001631 carbomer Drugs 0.000 claims abstract description 22
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 20
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 19
- 239000003906 humectant Substances 0.000 claims abstract description 13
- 239000004519 grease Substances 0.000 claims abstract description 8
- 239000012071 phase Substances 0.000 claims description 131
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 45
- 229940089951 perfluorooctyl triethoxysilane Drugs 0.000 claims description 44
- AVYKQOAMZCAHRG-UHFFFAOYSA-N triethoxy(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane Chemical group CCO[Si](OCC)(OCC)CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F AVYKQOAMZCAHRG-UHFFFAOYSA-N 0.000 claims description 44
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 30
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 22
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 20
- -1 polydimethylsiloxane Polymers 0.000 claims description 16
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 15
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 15
- 239000010445 mica Substances 0.000 claims description 14
- 229910052618 mica group Inorganic materials 0.000 claims description 14
- LPGFSDGXTDNTCB-UHFFFAOYSA-N [3-(16-methylheptadecanoyloxy)-2,2-bis(16-methylheptadecanoyloxymethyl)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC(C)C)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C LPGFSDGXTDNTCB-UHFFFAOYSA-N 0.000 claims description 13
- 239000008346 aqueous phase Substances 0.000 claims description 13
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims description 13
- 235000011187 glycerol Nutrition 0.000 claims description 11
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 11
- 239000004408 titanium dioxide Substances 0.000 claims description 11
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 6
- 230000003472 neutralizing effect Effects 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 230000002335 preservative effect Effects 0.000 claims description 6
- 239000000454 talc Substances 0.000 claims description 6
- 229910052623 talc Inorganic materials 0.000 claims description 6
- 239000007957 coemulsifier Substances 0.000 claims description 5
- NKEQOUMMGPBKMM-UHFFFAOYSA-N 2-hydroxy-2-[2-(2-hydroxy-3-octadecanoyloxypropoxy)-2-oxoethyl]butanedioic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CC(O)(C(O)=O)CC(O)=O NKEQOUMMGPBKMM-UHFFFAOYSA-N 0.000 claims description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 4
- 229920006037 cross link polymer Polymers 0.000 claims description 4
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 4
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 claims description 4
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 claims description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 3
- 229960003237 betaine Drugs 0.000 claims description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 3
- 229940113120 dipropylene glycol Drugs 0.000 claims description 3
- 229960005150 glycerol Drugs 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 229960004063 propylene glycol Drugs 0.000 claims description 3
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 3
- 230000000699 topical effect Effects 0.000 claims 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims 1
- 239000004909 Moisturizer Substances 0.000 claims 1
- 230000001333 moisturizer Effects 0.000 claims 1
- 239000002304 perfume Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 22
- 235000015110 jellies Nutrition 0.000 abstract description 4
- 239000008274 jelly Substances 0.000 abstract description 4
- 238000006243 chemical reaction Methods 0.000 abstract description 3
- 230000002045 lasting effect Effects 0.000 abstract description 3
- 230000000007 visual effect Effects 0.000 abstract description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 22
- 230000000052 comparative effect Effects 0.000 description 17
- 239000008367 deionised water Substances 0.000 description 13
- 229910021641 deionized water Inorganic materials 0.000 description 13
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 11
- 229910052742 iron Inorganic materials 0.000 description 11
- 229960005323 phenoxyethanol Drugs 0.000 description 11
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 10
- HFJHNGKIVAKCIW-UHFFFAOYSA-N Stearyl monoglyceridyl citrate Chemical compound OCC(O)CO.OC(=O)CC(O)(CC(O)=O)CC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O HFJHNGKIVAKCIW-UHFFFAOYSA-N 0.000 description 10
- UCNNJGDEJXIUCC-UHFFFAOYSA-L hydroxy(oxo)iron;iron Chemical compound [Fe].O[Fe]=O.O[Fe]=O UCNNJGDEJXIUCC-UHFFFAOYSA-L 0.000 description 10
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 10
- 150000002500 ions Chemical class 0.000 description 7
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 7
- 230000009471 action Effects 0.000 description 6
- MSRJTTSHWYDFIU-UHFFFAOYSA-N octyltriethoxysilane Chemical compound CCCCCCCC[Si](OCC)(OCC)OCC MSRJTTSHWYDFIU-UHFFFAOYSA-N 0.000 description 6
- 229960003493 octyltriethoxysilane Drugs 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000001038 titanium pigment Substances 0.000 description 6
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- UUJLHYCIMQOUKC-UHFFFAOYSA-N trimethyl-[oxo(trimethylsilylperoxy)silyl]peroxysilane Chemical compound C[Si](C)(C)OO[Si](=O)OO[Si](C)(C)C UUJLHYCIMQOUKC-UHFFFAOYSA-N 0.000 description 5
- 238000000265 homogenisation Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000010422 painting Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- PAFJZWHXMSQJKV-UQZRNVAESA-N (3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol;octadecanoic acid Chemical compound OC[C@@H](O)C1OC[C@H](O)[C@H]1O.OC[C@@H](O)C1OC[C@H](O)[C@H]1O.OC[C@@H](O)C1OC[C@H](O)[C@H]1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O PAFJZWHXMSQJKV-UQZRNVAESA-N 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 1
- AQKOHYMKBUOXEB-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-(16-methylheptadecanoyloxy)oxolan-2-yl]-2-(16-methylheptadecanoyloxy)ethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCC(C)C)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCC(C)C AQKOHYMKBUOXEB-RYNSOKOISA-N 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 229940071160 cocoate Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 229940099549 polyglycerin-3 Drugs 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 229940100515 sorbitan Drugs 0.000 description 1
- 229940057429 sorbitan isostearate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000012430 stability testing Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to a skin external composition and a skin external product, wherein the skin external composition comprises the following components in parts by weight: 65-90 parts of water phase, 4-14 parts of oil phase and 6-20 parts of powder phase; the water phase comprises carbomer, water, a humectant and a neutralizer, the oil phase comprises grease and an emulsifier, and the powder phase comprises hydrophobic and oleophobic powder. The composition is in a jelly shape, has an elastic effect, and provides brand new touch and visual sense; when the composition is used, the system of the composition is in an oil-in-water state, so that a user can obtain a fresh and moist skin feeling, then the system of the composition is in a critical state of mutual conversion between oil-in-water and water-in-oil, and finally the system of the composition is converted into a water-in-oil state, so that the user can obtain a moist and smooth skin feeling, and the composition has a lasting makeup-keeping effect. The hydrophobic and oleophobic powder can not affect the phase inversion, and can ensure that the color difference of the combined system can not occur after the phase inversion, and can better cover the flaw.
Description
Technical Field
The invention relates to the field of cosmetics, in particular to a skin external composition and a skin external product.
Background
Conventional foundation solutions are characterized by being of a single type of expression, i.e., all-oil, oil-in-water, or water-in-oil, after being applied to the skin. Wherein, the all-oil foundation liquid has light, thin and flaw-covering effect, but has high price and poor stability; the oil-in-water type foundation solution is fresh, moist and moisture-retaining, but has poor water resistance and poor make-up holding effect; the water-in-oil type foundation liquid is waterproof and sweat-proof, and can be used for a long time, but the painting feeling is heavy and the water feeling is lacked.
Disclosure of Invention
In view of the above, it is desirable to provide a composition for external application to skin and an external application to skin.
The invention provides a skin external composition which comprises the following components in parts by weight: 65-90 parts of water phase, 4-14 parts of oil phase and 6-20 parts of powder phase; the water phase comprises carbomer, water, a humectant and a neutralizer, the oil phase comprises grease and an emulsifier, and the powder phase comprises hydrophobic and oleophobic powder.
In one embodiment, the carbomer is 0.2 to 0.6 part by weight, the water is 37 to 82.5 parts by weight, the humectant is 7 to 20 parts by weight, the neutralizer is 0.1 to 0.6 part by weight, the oil is 3 to 10 parts by weight, the emulsifier is 0.8 to 2.0 parts by weight, and the hydrophobic and oleophobic powder is 6 to 20 parts by weight.
In one embodiment, the hydrophobic and oleophobic powder comprises a powder modified by perfluorooctyltriethoxysilane and hydrogenated lecithin.
In one embodiment, the powder material comprises at least one of titanium dioxide, iron oxide yellow, iron oxide red, iron oxide black, talc and mica.
In one embodiment, the carbomer comprises an acrylic/C10-30 alkanol acrylate crosspolymer.
In one embodiment, the neutralizing agent comprises at least one of aminomethyl propanol, triethanolamine.
In one embodiment, the emulsifier comprises at least one of polyglyceryl-3 distearate, glyceryl stearate citrate.
In one embodiment, the oil comprises at least one of hydrogenated polyisobutene, polydimethylsiloxane, pentaerythritol tetraisostearate, caprylic/capric/myristic/stearic triglyceride.
In one embodiment, the humectant comprises at least one of 1, 2-pentanediol, butanediol, glycerin, propylene glycol, dipropylene glycol, sodium hyaluronate, betaine.
In one embodiment, the oil phase further comprises at least one of a co-emulsifier, a film former.
In one embodiment, the aqueous phase further comprises a preservative.
In one embodiment, the composition further comprises a fragrance.
The invention also provides a skin external product which comprises the skin external composition.
In the composition, carbomer regulated by the neutralizing agent can be used as a gel matrix to adsorb water, so that the composition is in a jelly shape and has an elastic effect, and brand new touch feeling and visual feeling are provided.
In the using process, the composition is smeared on the skin, the structure of the carbomer is damaged after the carbomer is contacted with ions on the skin due to the fact that the carbomer is not resistant to the ions, adsorbed water is released instantly, and under the action of an emulsifier, the mass ratio of a water phase to an oil phase is combined, so that enough water is wrapped in the oil phase, the system of the composition is in an oil-in-water state, and a user can obtain fresh, water and moist skin feeling. As the coating process is carried out, water is gradually absorbed, the oil phase in the system is slowly released, and under the action of the emulsifier, the system of the composition is in a critical state of mutual conversion between oil-in-water and water-in-oil. Then, the critical state is broken through external force, so that the system of the composition is converted into a water-in-oil state, and the user obtains moist and smooth skin feel, and the composition is attached to the skin, so that the lasting makeup effect of the user is improved.
In the composition, the hydrophobic and oleophobic powder is dispersed on an oil phase, a water phase and a water-oil interface, and in the use process, along with the action of an external force, the hydrophobic and oleophobic powder gradually separates from the water phase, the oil phase and the water-oil interface and is attached to the skin to form a layer of protective film, so that the influence of the powder phase entering the water phase and the oil phase on the phase inversion of a composition system is avoided, and the color difference of an apparent color and a painting color of the composition system is avoided after the phase inversion. Meanwhile, the skin external composition has good stability and large adjustable range of the proportion of the powder phase, and can better cover flaws.
Drawings
FIG. 1 is a flowchart for performing a hydrophobicity test on a composition for external application to skin;
FIG. 2 is a flowchart of a state test before phase inversion of the skin external composition of example 6 and the water-in-oil foundation of comparative example 5;
FIG. 3 is a flowchart of a state test after phase inversion of the skin external composition of example 6 and the water-in-oil foundation of comparative example 5.
Detailed Description
The skin external composition and the skin external product provided by the present invention will be further described below.
The skin external composition provided by the invention comprises the following components in parts by weight: 65-90 parts of water phase, 4-14 parts of oil phase and 6-20 parts of powder phase; the water phase comprises carbomer, water, a humectant and a neutralizer, the oil phase comprises grease and an emulsifier, and the powder phase comprises hydrophobic and oleophobic powder.
In the composition, carbomer regulated by the neutralizing agent can be used as a gel matrix to adsorb water, so that the composition is in a jelly shape and has an elastic effect, and brand new touch feeling and visual feeling are provided.
In addition, the humectant is a component with a moisturizing effect in the water phase, the grease has a moisturizing effect, the emulsifier can disperse the oil phase in the water phase to promote the system to form an oil-in-water state or a critical state of converting oil-in-water into water-in-oil, and the hydrophobic oil-repellent powder can be separated from the water phase and the oil phase to form a protective film on the skin, so that the color difference of apparent color and painting color can not occur, and the state of the system can not be influenced.
Therefore, when the composition is applied to the skin in the using process, due to the fact that carbomer is not resistant to ions, the structure of carbomer is damaged after the carbomer contacts the ions on the skin, adsorbed water is released instantly, and under the action of an emulsifier, the mass ratio of the water phase to the oil phase is combined, so that enough water is wrapped in the oil phase, the system of the composition is in an oil-in-water state, and a user can obtain a fresh, water-wet skin feeling. As the coating process is carried out, water is gradually absorbed, the oil phase in the system is slowly released, and under the action of the emulsifier, the system of the composition is in a critical state of mutual conversion between oil-in-water and water-in-oil. Then, the critical state is broken through external force, so that the system of the composition is converted into a water-in-oil state, and the user obtains moist and smooth skin feel, and the composition is attached to the skin, so that the lasting makeup effect of the user is improved.
Regarding the powder phase, if titanium dioxide, toner, mica, talc and the like are not subjected to surface treatment, the powder phase shows hydrophilicity, on one hand, the surface of the hydrophilic powder generally has ions, and when carbomer meets the ions, the viscosity is reduced, so that a composition system is subjected to water discharge and floating powder, and on the other hand, the hydrophilic powder has poor skin feel such as dryness, is not resistant to water and sweat, has poor durability and is easily influenced by the external environment when being coated.
If the powder is treated by triethoxyoctyl siloxane, polydimethylsiloxane, etc. to show lipophilicity, the powder can easily enter oil phase from oil-water interface. In order to achieve the water-moistening effect, the oil phase content in the composition system is relatively low, and the oil phase is not enough to completely support the powder phase in the system, so that the system is easily influenced by the environment such as temperature, pH and the like, and the demulsification phenomenon is easily generated in the preparation process.
Therefore, the hydrophobic and oleophobic powder is used as a powder phase, the hydrophobic and oleophobic powder is dispersed on an oil phase, a water phase and a water-oil interface from the beginning, and the hydrophobic and oleophobic powder finally forms a layer of protective film on the skin along with the action of the external force, so that the color difference of apparent color and painting color of the system can not occur in the phase inversion process, and the system is prevented from entering the water phase and the oil phase to break the stability of each state.
Further, the weight parts of the carbomer are 0.2-0.6 part, the weight parts of the water are 37-82.5 parts, the weight parts of the humectant are 7-20 parts, the weight parts of the neutralizer is 0.1-0.6 part, the weight parts of the grease are 3-10 parts, the weight parts of the emulsifier is 0.8-2.0 parts, and the weight parts of the hydrophobic and oleophobic powder are 6-20 parts.
The hydrophobic and oleophobic powder comprises powder modified by perfluorooctyl triethoxysilane and hydrogenated lecithin in consideration of the hydrophobic and oleophobic effects, the processing procedure and the cost. The hydrogenated lecithin has high HLB value and certain emulsifying property, and can interact with an emulsifier in a system, so that the thickness of an oil-water interfacial film is increased, and the composition system is more stable.
The powder includes at least one of titanium dioxide, iron yellow, iron red, iron black, mica, talc, in consideration of the powder for adjusting color, hiding power, smoothness, etc. of the skin external composition. Specifically, in the powder material, iron yellow, iron red, iron black, mica and talc can be directly modified by perfluorooctyl triethoxysilane and hydrogenated lecithin; in order to better modify the titanium dioxide, a titanium dioxide coating layer can be added on the surface of the titanium dioxide and then modified.
The carbomer includes acrylic acid/C10-30 alkanol acrylate crosspolymer in consideration of the jelly-like shape brought by the effect of skin ion to achieve the gel effect of the phase inversion, retention system. Preferably, the acrylic/C10-30 alkanol acrylate crosspolymer includes at least one of TR-1, TR-2.
In order to better adjust the pH value of the system to be between 6 and 7 and enable the carbomer to better function in the environment after neutralization, the neutralizing agent comprises at least one of aminomethyl propanol and triethanolamine.
The emulsifier includes at least one of polyglycerin-3 distearate, glyceryl stearate citrate, in view of emulsification effect. Preferably, the emulsifier comprises polyglyceryl-3 distearate and glyceryl stearate citrate.
Specifically, the oil and fat comprises at least one of hydrogenated polyisobutene, polydimethylsiloxane, pentaerythritol tetraisostearate, and caprylic/capric/myristic/stearic triglyceride. The oil has good skin moistening effect, and can be used for regulating skin feeling.
Specifically, the humectant comprises at least one of 1, 2-pentanediol, butanediol, glycerol, propylene glycol, dipropylene glycol, sodium hyaluronate, and betaine. The humectant has good moisturizing effect and can increase water feeling of skin.
Further, the oil phase also comprises a coemulsifier, wherein the weight part of the coemulsifier is 0.2-1.2. Wherein, the auxiliary emulsifier preferably comprises at least one of sorbitan sesquioleate, sorbitan stearate, sorbitan sesquistearate, sorbitan triisostearate, sorbitan oleate, sorbitan isostearate, sorbitan sesquiisostearate and sorbitan cocoate.
Further, the oil phase also comprises a film forming agent for increasing the film forming effect of the system so as to further improve the water-resistant and sweat-resistant effect of the skin external composition. The weight part of the film forming agent is less than or equal to 8 parts, and the film forming agent preferably comprises at least one of trimethylsiloxysilicate and acrylic acid (ester)/polydimethylsiloxane copolymer.
Furthermore, the water phase also comprises a preservative, the preservative is 0.2-1.0 part by weight to improve the preservative performance of the skin external composition and prolong the shelf life of the skin external composition, and the preservative comprises at least one of phenoxyethanol, ethylhexyl glycerol and caprylyl glycol.
Further, the skin external composition also comprises essence for enhancing the fragrance of the skin external composition, and the weight part of the essence is 0.03-1.5 parts.
The preparation method of the skin external composition comprises the following steps:
s1, dispersing carbomer in deionized water, adding a humectant, heating to 75-85 ℃ for first homogenization, and continuously adding a neutralizer for second homogenization to obtain a first intermediate phase;
s2, mixing the first intermediate phase with the hydrophobic and oleophobic powder, and performing third homogenization to obtain a second intermediate phase;
s3, mixing the grease with the emulsifier to obtain a third intermediate phase;
s4, mixing the second intermediate phase with the third intermediate phase, heating to 65-70 ℃ for fourth homogenization to obtain a fourth intermediate phase;
and S5, cooling the fourth intermediate phase to room temperature under stirring to obtain the skin external composition.
Step S1, adding humectant and antiseptic, wherein the first homogenizing speed is 1000-3000 rpm, and the time is 3-6 min; the second homogenizing speed is 1000rpm-3000rpm, and the time is 1min-3 min.
In step S2, the speed of the third homogenizing is 3500rpm-7500rpm, and the time is 5min-10 min.
In step S3, a film-forming agent and a co-emulsifier can be added and mixed while the grease and the emulsifier are mixed; mixing, heating to 75-80 deg.c and re-dispersing to obtain the third intermediate phase.
In step S4, the fourth homogenizing speed is 3500rpm-7500rpm, and the time is 5min-10 min.
In step S5, the fourth intermediate phase may be first stirred to 40-45 deg.C, then added with essence and stirred, and finally cooled to room temperature to obtain the skin external composition.
The invention also provides a skin external product which comprises the skin external composition.
It is understood that since the skin external preparation includes the skin external composition, the skin external preparation also has the advantages of the skin external composition described above, and thus, the description thereof will be omitted.
Specifically, the skin external product can be foundation liquid.
Hereinafter, the skin external composition and the skin external product will be further described with reference to the following specific examples.
Example 1
The skin external composition of this example comprises 85kg of aqueous phase, 4.90kg of oil phase, 10kg of powder phase and 0.10kg of essence.
The water phase components comprise 2kg of 1, 2-pentanediol, 5kg of glycerol, 20.2kg of TR, 0.80kg of phenoxyethanol, 0.10kg of aminomethyl propanol and 76.9kg of deionized water;
the oil phase components comprise 0.90kg of polyglycerol-3 distearate, 0.10kg of glycerol stearate citrate, 0.40kg of sorbitan sesquioleate, 1.00kg of hydrogenated polyisobutene, 2.00kg of polydimethylsiloxane and 0.50kg of pentaerythritol tetraisostearate;
the powder phase comprises 6.00kg of titanium pigment modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 1.00kg of iron yellow modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 0.50kg of iron red modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 0.50kg of iron black modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, and 2.00kg of mica modified by perfluorooctyl triethoxysilane and hydrogenated lecithin.
Example 2
The skin external composition of this example comprises 82.57kg of aqueous phase, 5.60kg of oil phase, 11.70kg of powder phase and 0.10kg of essence.
The water phase components comprise 2kg of 1, 2-pentanediol, 5kg of butanediol, 20.4kg of TR, 0.63kg of phenoxyethanol, 0.07kg of ethylhexyl glycerol, 0.10kg of aminomethyl propanol and 74.55kg of deionized water;
the oil phase components comprise 0.88kg of polyglycerol-3 distearate, 0.12kg of glycerol stearate citrate, 0.60kg of sorbitan sesquioleate, 1.00kg of hydrogenated polyisobutene, 2.00kg of polydimethylsiloxane and 1.00kg of pentaerythritol tetraisostearate;
the powder phase comprises 8.00kg of titanium pigment modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 1.40kg of iron yellow modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 0.80kg of iron red modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 0.50kg of iron black modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, and 1.00kg of talc modified by perfluorooctyl triethoxysilane and hydrogenated lecithin.
Example 3
The skin external composition of this example comprises 74.80kg of aqueous phase, 9.30kg of oil phase, 15.80kg of powder phase and 0.10kg of essence.
The water phase components comprise 2kg of 1, 2-pentanediol, 5kg of glycerol, 20.4kg of TR, 0.64kg of phenoxyethanol, 0.16kg of octyl glycol, 0.40kg of triethanolamine and 66.20kg of deionized water;
the oil phase components comprise 0.9kg of polyglycerol-3 distearate, 0.10kg of glycerol stearate citrate, 0.80kg of sorbitan monostearate, 2.00kg of hydrogenated polyisobutene, 3.00kg of polydimethylsiloxane, 0.50kg of pentaerythritol tetraisostearate and 2.00kg of trimethylsiloxy silicate;
the powder phase comprises 10.00kg of titanium pigment modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 1.80kg of iron yellow modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 1.20kg of iron oxide red modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 0.80kg of iron black modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, and 2.00kg of mica modified by perfluorooctyl triethoxysilane and hydrogenated lecithin.
Example 4
The skin external composition of this example comprises 73.80kg of aqueous phase, 10.30kg of oil phase, 15.80kg of powder phase and 0.10kg of essence.
The water phase components comprise 2kg of 1, 2-pentanediol, 5kg of glycerin, 10.3kg of TR, 0.80kg of phenoxyethanol and neutralizing components: 0.30kg of triethanolamine and 65.40kg of deionized water;
the oil phase components comprise 1.80kg of polyglycerol-3 distearate, 0.20kg of glycerol stearate citrate, 0.80kg of sorbitan sesquioleate, 2.00kg of hydrogenated polyisobutene, 3.00kg of polydimethylsiloxane, 0.50kg of pentaerythritol tetraisostearate and 2.00kg of trimethylsiloxy silicate;
the powder phase comprises 10.00kg of titanium pigment modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 1.80kg of iron yellow modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 1.20kg of iron oxide red modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 0.80kg of iron black modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, and 2.00kg of mica modified by perfluorooctyl triethoxysilane and hydrogenated lecithin.
Example 5
The skin external composition of this example comprises 74.80kg of aqueous phase, 9.30kg of oil phase, 15.80kg of powder phase and 0.10kg of essence.
The water phase components comprise 5kg of butanediol, 10.3kg of TR-10.3kg of phenoxyethanol, 0.80kg of triethanolamine and 49.40kg of deionized water;
the oil phase components comprise 0.9kg of polyglycerol-3 distearate, 0.1kg of glycerol stearate citrate, 0.80kg of sorbitan sesquioleate, 2.00kg of hydrogenated polyisobutene, 3.00kg of polydimethylsiloxane, 0.50kg of pentaerythritol tetraisostearate and 2.00kg of trimethylsiloxy silicate;
the powder phase comprises 10.00kg of titanium pigment modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 1.80kg of iron yellow modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 1.20kg of iron oxide red modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 0.80kg of iron black modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, and 2.00kg of mica modified by perfluorooctyl triethoxysilane and hydrogenated lecithin.
Example 6
The skin external composition of this example comprises 74.80kg of aqueous phase, 9.30kg of oil phase, 15.80kg of powder phase and 0.10kg of essence.
The water phase components comprise 4kg of butanediol, 5kg of glycerol, 20.3kg of TR-20.3kg of phenoxyethanol, 0.72kg of ethylhexyl glycerol, 0.08kg of aminomethyl propanol and 64.55kg of deionized water;
the oil phase components comprise 0.50kg of polyglycerol-3 distearate, 0.50kg of glycerol stearate citrate, 0.40kg of sorbitan sesquioleate, 2.00kg of hydrogenated polyisobutene, 2.00kg of polydimethylsiloxane, 0.50kg of pentaerythritol tetraisostearate, 2.00kg of caprylic/capric/myristic/stearic triglyceride and 2.00kg of trimethylsiloxysilicate;
the powder phase comprises 6.80kg of titanium dioxide modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 1.80kg of iron yellow modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 1.20kg of iron red modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 0.80kg of iron black modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, and 2.00kg of mica modified by perfluorooctyl triethoxysilane and hydrogenated lecithin.
Comparative example 1
The skin external composition of this example comprises 85.0kg of aqueous phase, 4.90kg of oil phase, 10.0kg of powder phase and 0.10kg of essence.
The water phase comprises 2kg of 1, 2-pentanediol, 5kg of glycerol, 20.2kg of TR, 0.80kg of phenoxyethanol, 0.10kg of aminomethyl propanol and 76.90kg of deionized water;
the oil phase components comprise 0.90kg of polyglycerol-3 distearate, 0.10kg of glycerol stearate citrate, 0.40kg of sorbitan sesquioleate, 1.00kg of hydrogenated polyisobutene, 2.00kg of polydimethylsiloxane and 0.50kg of pentaerythritol tetraisostearate;
the powder phase comprises 6.00kg of titanium dioxide modified by triethoxyoctylsilane, 1.00kg of iron oxide yellow modified by triethoxyoctylsilane, 0.50kg of iron oxide red modified by triethoxyoctylsilane, 0.50kg of iron oxide black modified by triethoxyoctylsilane and 2.00kg of mica modified by triethoxyoctylsilane.
Comparative example 2
The skin external composition of this example comprises 85.0kg of aqueous phase, 4.90kg of oil phase, 10.0kg of powder phase and 0.10kg of essence.
The water phase comprises 2kg of 1, 2-pentanediol, 5kg of glycerol, 20.2kg of TR, 0.80kg of phenoxyethanol, 0.10kg of aminomethyl propanol and 76.90kg of deionized water;
the oil phase components comprise 0.90kg of polyglycerol-3 distearate, 0.10kg of glycerol stearate citrate, 0.40kg of sorbitan sesquioleate, 1.00kg of hydrogenated polyisobutene, 2.00kg of polydimethylsiloxane and 0.50kg of pentaerythritol tetraisostearate;
the powder phase components comprise 6.00kg of titanium dioxide, 1.00kg of iron yellow, 0.50kg of iron red, 0.50kg of iron black and 2.00kg of mica.
Comparative example 3
The skin external composition of this example comprises 97.33kg of aqueous phase, 0.41kg of oil phase, 2.16kg of powder phase and 0.10kg of essence.
The water phase comprises 5.00kg of 1, 2-pentanediol, 15.00kg of glycerol, 20.9kg of TR-20.9kg of phenoxyethanol, 0.40kg of aminomethyl propanol and 75.45kg of deionized water;
the oil phase components comprise 0.18kg of polyglycerol-3 distearate, 0.02kg of glycerol stearate citrate, 0.02kg of sorbitan sesquioleate, 0.05kg of hydrogenated polyisobutene, 0.04kg of polydimethylsiloxane and 0.10kg of pentaerythritol tetraisostearate;
the powder phase comprises 2kg of titanium dioxide modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 0.02kg of iron yellow modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 0.01kg of iron oxide red modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 0.01kg of iron oxide black modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, and 0.10kg of mica modified by perfluorooctyl triethoxysilane and hydrogenated lecithin.
Comparative example 4
The skin external composition of this example comprises 55.90kg of aqueous phase, 30.00kg of oil phase, 10.00kg of powder phase and 0.10kg of essence.
The water phase components comprise 2.00kg of 1, 2-pentanediol, 5.00kg of glycerol, 20.20kg of TR, 0.20kg of phenoxyethanol, 0.10kg of aminomethyl propanol and 48.40kg of deionized water;
the oil phase components comprise 3.60kg of polyglycerol-3 distearate, 0.40kg of glycerol stearate citrate, 2.00kg of sorbitan sesquioleate, 8.00kg of hydrogenated polyisobutene, 8.00kg of polydimethylsiloxane and 8.00kg of pentaerythritol tetraisostearate;
the powder phase comprises 6.00kg of titanium pigment modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 1.00kg of iron yellow modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 0.50kg of iron red modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, 0.50kg of iron black modified by perfluorooctyl triethoxysilane and hydrogenated lecithin, and 2.00kg of mica modified by perfluorooctyl triethoxysilane and hydrogenated lecithin.
Comparative example 5
A commercially available version of a water-in-oil foundation is provided.
Results of the experiment
And (3) observing appearance forms: the appearance forms of the skin external compositions of examples 1 to 5 and comparative examples 1 to 4 were directly observed, and the results of the appearance form observation are shown in table 1.
Hydrophobicity test: the skin external composition of examples 1 to 5 and comparative examples 1 to 4 was uniformly applied to the skin, and the skin was rinsed with natural running water 10 seconds away from the skin by 10.0cm, and then the portion applied with the skin external composition was pressed with a paper towel 10 seconds before observing whether the paper towel was stained with the skin external composition. The skin external composition was not washed off and was not stuck to a paper towel, indicating good hydrophobicity, and the results of the hydrophobicity test are shown in table 1.
And (3) stability testing: the skin external compositions of examples 1 to 5 and comparative examples 1 to 4 were left under light at 25 deg.C, 48 deg.C, -18 deg.C for 3 months, respectively. If any phenomenon of alkene change, demulsification, delamination and oil production occurs, the stability is not stable, otherwise, the stability is ensured, and the stability test result is shown in table 2.
Testing the phase inversion effect: equal amounts of the external composition for skin a of example 6 and the water-in-oil foundation B of comparative example 5 were taken. Referring to fig. 2, the composition for external application to skin a of example 6 and the water-in-oil foundation solution B of comparative example 5 were applied to the skin immediately after application, and two drops of deionized water were dropped to observe changes; referring to fig. 3, the composition for external application to skin a of example 6 and the water-in-oil foundation B of comparative example 5 were applied uniformly to the skin, and after complete phase inversion, two drops of deionized water were dropped to observe the change, and the phase inversion effect was measured as shown in table 3.
The powder phase in the skin external composition of comparative example 1 was modified with triethoxyoctylsilane, and was too lipophilic to be in an unstable water-in-oil state, and could not form a jelly shape, and also could not achieve the phase inversion effect; the powder phase in the skin external composition of comparative example 2 was not treated, the hydrophilicity was strong, and the phase inversion effect could not be achieved; the composition for external application to skin of comparative example 3 had a high proportion of aqueous phase, was in an oil-in-water state, and could not achieve the phase inversion effect; the composition for external application to skin of comparative example 4 has a high proportion of oil phase, and at the same time has low carbomer and water contents, is in a water-in-oil state, cannot form a jelly-like state, and cannot achieve phase inversion effect.
TABLE 1
TABLE 2
TABLE 3
The technical features of the embodiments described above may be arbitrarily combined, and for the sake of brevity, all possible combinations of the technical features in the embodiments described above are not described, but should be considered as being within the scope of the present specification as long as there is no contradiction between the combinations of the technical features.
The above-mentioned embodiments only express several embodiments of the present invention, and the description thereof is more specific and detailed, but not construed as limiting the scope of the invention. It should be noted that, for a person skilled in the art, several variations and modifications can be made without departing from the inventive concept, which falls within the scope of the present invention. Therefore, the protection scope of the present patent shall be subject to the appended claims.
Claims (13)
1. The skin external composition is characterized by comprising the following components in parts by weight: 65-90 parts of water phase, 4-14 parts of oil phase and 6-20 parts of powder phase; the water phase comprises carbomer, water, a humectant and a neutralizer, the oil phase comprises grease and an emulsifier, and the powder phase comprises hydrophobic and oleophobic powder.
2. The composition for external application to skin according to claim 1, wherein the carbomer is in an amount of 0.2 to 0.6 parts by weight, the water is in an amount of 37 to 82.5 parts by weight, the humectant is in an amount of 7 to 20 parts by weight, the neutralizer is in an amount of 0.1 to 0.6 parts by weight, the oil is in an amount of 3 to 10 parts by weight, the emulsifier is in an amount of 0.8 to 2.0 parts by weight, and the hydrophobic and oleophobic powder is in an amount of 6 to 20 parts by weight.
3. The composition for external application to skin according to claim 1, wherein the hydrophobic and oleophobic powder comprises a powder modified with perfluorooctyltriethoxysilane and hydrogenated lecithin.
4. The composition for skin external use according to claim 3, wherein the powder material comprises at least one of titanium dioxide, iron oxide yellow, iron oxide red, iron oxide black, talc and mica.
5. The topical composition for skin of claim 1, wherein the carbomer comprises an acrylic/C10-30 alkanol acrylate crosspolymer.
6. The topical skin composition of claim 1, wherein the neutralizing agent comprises at least one of aminomethyl propanol, triethanolamine.
7. The topical composition for skin according to claim 1, wherein the emulsifier comprises at least one of polyglyceryl-3 distearate, glyceryl stearate citrate.
8. The composition for external application to skin according to claim 1, wherein the oil or fat comprises at least one of hydrogenated polyisobutene, polydimethylsiloxane, pentaerythritol tetraisostearate, caprylic/capric/myristic/stearic triglyceride.
9. The composition for external application to skin as claimed in claim 1, wherein the moisturizer comprises at least one of 1, 2-pentanediol, butylene glycol, glycerin, propylene glycol, dipropylene glycol, sodium hyaluronate, and betaine.
10. The topical composition for skin according to claim 1, wherein the oil phase further comprises at least one of a co-emulsifier, a film-forming agent.
11. The topical composition for skin according to claim 1, wherein the aqueous phase further comprises a preservative.
12. The composition for external application to skin as claimed in claim 1, wherein the composition further comprises a perfume.
13. A skin external product comprising the skin external composition according to any one of claims 1 to 12.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010752872.9A CN111686034A (en) | 2020-07-30 | 2020-07-30 | Composition for external application to skin and external product for skin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010752872.9A CN111686034A (en) | 2020-07-30 | 2020-07-30 | Composition for external application to skin and external product for skin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111686034A true CN111686034A (en) | 2020-09-22 |
Family
ID=72487081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010752872.9A Pending CN111686034A (en) | 2020-07-30 | 2020-07-30 | Composition for external application to skin and external product for skin |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111686034A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4268904A1 (en) * | 2022-04-26 | 2023-11-01 | Chanel Parfums Beauté | Stable high internal phase emulsions and compositions comprising the same |
Citations (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014167543A1 (en) * | 2013-04-12 | 2014-10-16 | L'oreal | Gel-type cosmetic composition |
| CN104940044A (en) * | 2015-06-30 | 2015-09-30 | 广州环亚化妆品科技有限公司 | Foundation cream with stable wire-drawing effect and preparation method of foundation cream |
| WO2017129237A1 (en) * | 2016-01-27 | 2017-08-03 | L'oreal | Gel-gel composition containing salicylic acid, one alkanolamine and pigments |
| CN107496187A (en) * | 2017-08-22 | 2017-12-22 | 上海蔻沣生物科技有限公司 | A kind of cosmetic pigment powder for pasting the fabulous hydrophobic oleophobic of skin and its preparation method and application |
| CN107714536A (en) * | 2017-10-19 | 2018-02-23 | 苏州安特化妆品股份有限公司 | It is long-acting to hold adornment air cushion BB frosts and preparation method thereof |
| CN107823040A (en) * | 2017-10-31 | 2018-03-23 | 苏州安特化妆品股份有限公司 | It is long-acting to hold adornment muffin and preparation method thereof |
| CN108283584A (en) * | 2018-03-31 | 2018-07-17 | 佛山娇芙生物科技有限公司 | It is a kind of that there is the foundation emulsion for well holding adornment |
| CN108371637A (en) * | 2018-03-31 | 2018-08-07 | 佛山文森特知识产权服务有限公司 | A kind of slim and graceful foundation cream of oil-in-water |
| CN109223597A (en) * | 2018-11-26 | 2019-01-18 | 广州艾蓓生物科技有限公司 | One kind holding adornment foundation emulsion |
| CN109330936A (en) * | 2018-11-02 | 2019-02-15 | 广州丽彦妆生物科技有限公司 | A kind of sun-proof foundation emulsion of anti-aging and preparation method thereof |
| CN109330927A (en) * | 2018-11-02 | 2019-02-15 | 广州丽彦妆生物科技有限公司 | One kind, which is moistened, repairs plain face frost and preparation method thereof |
| CN109481325A (en) * | 2018-11-02 | 2019-03-19 | 广州丽彦妆生物科技有限公司 | It is a kind of to repair face beauty cream and preparation method thereof containing the continuous double thin powder of flower Chinese bush cherry |
| CN109833214A (en) * | 2019-03-14 | 2019-06-04 | 广州澳希亚实业有限公司 | A kind of mild oil-in-water type pickering sunlight screening skin-protecting product and preparation method thereof |
| CN109939053A (en) * | 2019-04-28 | 2019-06-28 | 普宁市嘉宝日用化工有限公司 | Dual-purpose muffin of a kind of tender moisturizing of water and preparation method thereof |
| CN110200851A (en) * | 2019-07-19 | 2019-09-06 | 广州花出见生物科技有限公司 | A kind of air cushion repairs Yan Shuan and preparation method thereof |
-
2020
- 2020-07-30 CN CN202010752872.9A patent/CN111686034A/en active Pending
Patent Citations (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014167543A1 (en) * | 2013-04-12 | 2014-10-16 | L'oreal | Gel-type cosmetic composition |
| CN104940044A (en) * | 2015-06-30 | 2015-09-30 | 广州环亚化妆品科技有限公司 | Foundation cream with stable wire-drawing effect and preparation method of foundation cream |
| WO2017129237A1 (en) * | 2016-01-27 | 2017-08-03 | L'oreal | Gel-gel composition containing salicylic acid, one alkanolamine and pigments |
| CN107496187A (en) * | 2017-08-22 | 2017-12-22 | 上海蔻沣生物科技有限公司 | A kind of cosmetic pigment powder for pasting the fabulous hydrophobic oleophobic of skin and its preparation method and application |
| CN107714536A (en) * | 2017-10-19 | 2018-02-23 | 苏州安特化妆品股份有限公司 | It is long-acting to hold adornment air cushion BB frosts and preparation method thereof |
| CN107823040A (en) * | 2017-10-31 | 2018-03-23 | 苏州安特化妆品股份有限公司 | It is long-acting to hold adornment muffin and preparation method thereof |
| CN108283584A (en) * | 2018-03-31 | 2018-07-17 | 佛山娇芙生物科技有限公司 | It is a kind of that there is the foundation emulsion for well holding adornment |
| CN108371637A (en) * | 2018-03-31 | 2018-08-07 | 佛山文森特知识产权服务有限公司 | A kind of slim and graceful foundation cream of oil-in-water |
| CN109330936A (en) * | 2018-11-02 | 2019-02-15 | 广州丽彦妆生物科技有限公司 | A kind of sun-proof foundation emulsion of anti-aging and preparation method thereof |
| CN109330927A (en) * | 2018-11-02 | 2019-02-15 | 广州丽彦妆生物科技有限公司 | One kind, which is moistened, repairs plain face frost and preparation method thereof |
| CN109481325A (en) * | 2018-11-02 | 2019-03-19 | 广州丽彦妆生物科技有限公司 | It is a kind of to repair face beauty cream and preparation method thereof containing the continuous double thin powder of flower Chinese bush cherry |
| CN109223597A (en) * | 2018-11-26 | 2019-01-18 | 广州艾蓓生物科技有限公司 | One kind holding adornment foundation emulsion |
| CN109833214A (en) * | 2019-03-14 | 2019-06-04 | 广州澳希亚实业有限公司 | A kind of mild oil-in-water type pickering sunlight screening skin-protecting product and preparation method thereof |
| CN109939053A (en) * | 2019-04-28 | 2019-06-28 | 普宁市嘉宝日用化工有限公司 | Dual-purpose muffin of a kind of tender moisturizing of water and preparation method thereof |
| CN110200851A (en) * | 2019-07-19 | 2019-09-06 | 广州花出见生物科技有限公司 | A kind of air cushion repairs Yan Shuan and preparation method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4268904A1 (en) * | 2022-04-26 | 2023-11-01 | Chanel Parfums Beauté | Stable high internal phase emulsions and compositions comprising the same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102292065B (en) | Emulsion cosmetic | |
| KR101493134B1 (en) | Pigment for cosmetic preparations, method for producing same, and cosmetic preparation containing the pigment for cosmetic preparations | |
| CN110339146B (en) | Water-in-oil-in-water foundation liquid and preparation method thereof | |
| CN114224753A (en) | Water-in-oil type emulsified composition, foundation liquid and preparation method thereof | |
| JPH04230207A (en) | Cosmetic material | |
| KR101975850B1 (en) | Eye make-up cosmetic composition | |
| JP5182865B2 (en) | Oily salmon cosmetic | |
| JP2000063261A (en) | Reparation for external use for skin | |
| CN111686034A (en) | Composition for external application to skin and external product for skin | |
| JP6133574B2 (en) | Water-based eyeliner cosmetic | |
| JPS62215510A (en) | Emulsified composition | |
| JP3854522B2 (en) | Makeup cosmetics | |
| JPH04308520A (en) | W/o-type make-up cosmetic | |
| JP6105300B2 (en) | Oil-in-water makeup cosmetics | |
| CN111712224A (en) | Water-in-oil type cosmetic composition having improved staying power and improved dry feeling | |
| US7488472B2 (en) | Cosmetic composition for eyelashes | |
| JP2018177757A (en) | Cosmetic | |
| KR100702340B1 (en) | Make-up Cosmetic Composition of Water-in-oil Type Containing Lecithin | |
| TW202128125A (en) | External preparation for skin | |
| JP4310008B2 (en) | Cosmetics | |
| WO2016099892A1 (en) | Waterproof mascara composition | |
| KR100262763B1 (en) | Lipstick composition | |
| JP2003183131A (en) | Mascara overcoat | |
| KR102557833B1 (en) | Cosmetic composition including capsules for base makeup and preparing method thereof | |
| KR102302622B1 (en) | Semi solid type color cosmetic composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200922 |
|
| RJ01 | Rejection of invention patent application after publication |